Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002108224 | SCV002398783 | likely benign | not provided | 2025-01-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002499984 | SCV002811427 | likely benign | Chronic myelogenous leukemia, BCR-ABL1 positive; Congenital heart defects and skeletal malformations syndrome | 2021-10-19 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002108224 | SCV004156528 | benign | not provided | 2024-11-01 | criteria provided, single submitter | clinical testing | ABL1: BS1, BS2 |
Breakthrough Genomics, |
RCV002108224 | SCV005225872 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV004543799 | SCV004770483 | likely benign | ABL1-related disorder | 2022-06-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |